Big Move For Summit Therapeutics plc
Wed, Dec 07, 2022 at 07:00 PM
Summit Therapeutics plc (SMMT:NASDAQ) shot up at $3.08, a gain of 33.3%. On Wed, Dec 07, 2022, SMMT:NASDAQ touched a New 2-Week High of $3.08. The stock got featured on our News Catalysts scanner on Tue, Dec 06, 2022 at 12:43 PM in the 'AGREEMENT' category. From Wed, Nov 23, 2022, the stock recorded 55.56% Up Days and 70.00% Green Days
About Summit Therapeutics plc (SMMT:NASDAQ)
Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.
Top 10 Gainers:
- Ignyta, Inc. (RXDX:NASDAQ), 165.67%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 133.44%
- FLJ Group Limited (FLJ:NASDAQ), 57.3%
- Vor Biopharma Inc. (VOR:NASDAQ), 41.86%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 37.16%
- Summit Therapeutics plc (SMMT:NASDAQ), 33.33%
- NexGel Inc (NXGL:NASDAQ), 28.33%
- Eargo Inc. (EAR:NASDAQ), 27.48%
- Bit Brother Limited (BTB:NASDAQ), 23.65%
- MongoDB, Inc. (MDB:NASDAQ), 23.23%